Diagnosis of generalized pustular psoriasis

H Fujita, M Gooderham, R Romiti - American Journal of Clinical …, 2022 - Springer
Generalized pustular psoriasis (GPP) is a severe rare skin disease characterized by
widespread eruption of sterile superficial macroscopic pustules with or without systemic …

Multisystem inflammatory syndrome and autoimmune diseases following COVID-19: molecular mechanisms and therapeutic opportunities

P Hosseini, MS Fallahi, G Erabi, M Pakdin… - Frontiers in molecular …, 2022 - frontiersin.org
Coronavirus disease 2019 (COVID-19), caused by severe acute respiratory syndrome-
coronavirus 2 (SARS-CoV-2), has led to huge concern worldwide. Some SARS-CoV-2 …

Autoimmune and autoinflammatory connective tissue disorders following COVID-19

SH Lim, HJ Ju, JH Han, JH Lee, WS Lee… - JAMA network …, 2023 - jamanetwork.com
Importance Multiple cases of autoimmune and autoinflammatory diseases after COVID-19
have been reported. However, their incidences and risks have rarely been quantified …

National Psoriasis Foundation COVID-19 Task Force guidance for management of psoriatic disease during the pandemic: Version 2—Advances in psoriatic disease …

JM Gelfand, AW Armstrong, S Bell, GL Anesi… - Journal of the American …, 2021 - Elsevier
Objective To update guidance regarding the management of psoriatic disease during the
COVID-19 pandemic. Study Design The task force (TF) includes 18 physician voting …

Generalized pustular psoriasis: a review on clinical characteristics, diagnosis, and treatment

R Rivera-Díaz, E Daudén, JM Carrascosa… - Dermatology and …, 2023 - Springer
Generalized pustular psoriasis (GPP) is a rare, chronic, and severe inflammatory skin
disorder characterized by sudden eruption of sterile pustules, often accompanied by …

De novo generalized pustular psoriasis following Oxford‐AstraZeneca COVID‐19 vaccine

S Elamin, F Hinds, J Tolland - Clinical and experimental …, 2022 - academic.oup.com
De novo generalized pustular psoriasis following Oxford‐AstraZeneca COVID‐19 vaccine |
Clinical and Experimental Dermatology | Oxford Academic Skip to Main Content …

COVID‐19 and exacerbation of dermatological diseases: a review of the available literature

K Aram, A Patil, M Goldust, F Rajabi - Dermatologic Therapy, 2021 - Wiley Online Library
Since the emergence of the new coronavirus disease 19 (COVID‐19) pandemic, there has
been a concern for the patients with chronic autoimmune diseases including dermatological …

Pansclerotic morphea following COVID-19: A case report and review of literature on rheumatologic and non-rheumatologic dermatologic immune-mediated disorders …

Z Lotfi, A Haghighi, A Akbarzadehpasha… - Frontiers in …, 2021 - frontiersin.org
While mucocutaneous manifestations of COVID-19 have been frequently reported and
added to our knowledge every day during the pandemic, another issue is the COVID-related …

Sociodemographic, clinical, laboratory, treatment and prognostic characteristics of 156 generalized pustular psoriasis patients in Turkey: a multicentre case series

A Kara Polat, E Alpsoy, G Kalkan… - Journal of the …, 2022 - Wiley Online Library
Background Generalized pustular psoriasis (GPP) is a rare and severe inflammatory
disease characterized by widespread and superficial sterile pustules on an erythematous …

Biologics for psoriasis during the COVID-19 pandemic

H Zeng, S Wang, L Chen, Z Shen - Frontiers in medicine, 2021 - frontiersin.org
Coronavirus disease 2019 (COVID-19), a new form of acute infectious respiratory syndrome
first reported in 2019, has rapidly spread worldwide and has been recognized as a …